A woman gives her swab and test kit to medical staff before receiving a nucleic acid test for Covid-19 at a private testing site on January 17, 2022 in Beijing, China .
Kevin Frayer | Getty Images News | beautiful pictures
According to US investment bank Morgan Stanley, the economic costs of China’s zero-Covid policy are increasingly expected to outweigh its benefits.
China’s zero tolerance for Covid puts the country at a disadvantage compared to other countries with endemic strategies, Laura Wang, their China equity strategist, told CNBC’s Emily Tan.
In January, the US investment bank cut its forecast for China’s first-quarter GDP – lowering its estimate to 4.5% year-on-year growth, from its previous forecast of 4.5%. ,9%.
“We [started] “This year, the buffer from an increase in exports may not be as high as… last year because of many other countries and markets,” said Wang. [are] reopened. “
“As a result, we are expecting a larger consensus decline in earnings. At this point, we think investors are still being overly optimistic with their expectations for corporate earnings,” she said. speak.
Wang said the bank favors A-shares over MSCI China for 2022. A-shares are yuan shares of companies based in mainland China, traded on exchanges. Chinese stocks in Shanghai and Shenzhen.
The bank expects the CSI 300 index to hit 5,250 by year-end and the MSCI China index to hit 95 in the same period. The CSI 300 is currently trading at around 4,680 after losing about 5% this year. The MSCI China index, which foreign investors often use as a benchmark, is hovering around 82 – 1.3% lower than at the start of the year.
As reported by Morgan Stanley on January 16, “increased uncertainty due to the overland spread of omicrons [and] Default risk in the property market “is some reason to remain cautious for Chinese stocks.
Morgan Stanley maintained its initial forecast for full year 2022 of 5.5% growth for China, but noted that it continues to see downside risks from potential closures because of “Q1 losses. can hardly be compensated.”
The bank does not expect a change in its zero-Covid policy before the second half of 2022.
“The biggest pressure will be on private consumption, as the rise of social distancing and local/regional deadlock may become inevitable. Actual Lunar New Year (LNY) ) is increasingly likely with China’s ‘Covid-zero’, Morgan Stanley analysts said.
China report The first omicron Covid in December and continues to see the community spread throughout the cities. Beijing officials are also staying.”Full emergency mode“on the eve of the Winter Olympic Games and the tourist season of the Lunar New Year.
Despite cutting its first-quarter GDP growth forecast, Morgan Stanley noted that “recovery could regain ground amid policy easing.”
Earlier this week, People’s Bank of China cuts reverse repos rate 14 days to 2.25%, down from 2.35%, to “maintain stable liquidity ahead of the Lunar New Year, Reuters reported.
Analysts generally expect the Chinese economy to pick up after the first quarter as stimulus and monetary easing measures are expected.
Catherine Yeung, chief investment officer at Fidelity International, said China is likely to outperform other markets this year.
The biggest risk for China is the “policy mistake” of zero tolerance – “even if it isn’t supported early enough. [or] She told CNBC whether it is being overstated.
Morgan Stanley sees “downside risk to FY22 growth from housing,” but selected four stocks in the real estate sector that are considered high-quality developers in “safe harbor.” away from potential market turmoil.
The Wall Street bank remains bullish on tech hardware and the semiconductor industry, but cautious on China ADR, e-commerce and internet stocks.
“Converse surprises for US inflation and a shift in hawkish Fed policy could also trigger more volatility in growth stocks,” the bank wrote.